Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Zenas BioPharma granted non-qualified stock options and restricted stock units to new employees as an employment inducement on June 15, 2026. The awards consist of 100,000 stock options with an exercise price of $18.71 and 78,075 RSUs, both subject to four-year vesting schedules.
Key figures
- Rsus granted
- 78075
- Exercise price
- 18.71
- Options granted
- 100000
- Vesting term years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.